Westat’s clinical research solutions help clients efficiently bring important treatments and therapeutics to market to tackle chronic health conditions and emerging infectious diseases. Our deep experience has greatly expanded current knowledge about diseases, advancing health outcomes for society at large.
Providing full-service or stand-alone support, Westat is a leader in clinical research. We are experts in designing, managing, monitoring, and delivering advanced clinical trials and epidemiological studies. We have research experience in chronic diseases, including HIV/AIDS, cancer, diabetes, influenza, tuberculosis, COVID-19, emerging infectious diseases, and more. We support research in vaccine, gene therapy, monoclonal, and pediatric studies. Our expert interdisciplinary team includes epidemiologists, biostatisticians, data managers, and regulatory affairs associates. Through research coordination and real-world data collection and analysis, we bring innovative solutions that can help efficiently bring treatments and therapeutics to market and address important epidemiological questions.
Building on 60 years of clinical research experience, Westat serves as a Contract Research Organization (CRO) investigating promising new drugs and therapeutics. Our team has experience designing and implementing clinical trials for oncology, pediatrics, infectious diseases, vaccines, rare and emerging diseases, and more. Learn more about our expertise in therapeutic areas at the Westat CLS website. We work as an extension of your team, designing and implementing innovative, rigorous, credible clinical trials that deliver high value and cost efficiency. Westat will partner with you every step of the way—addressing challenges with creativity and integrity. We have proven our ability to quickly adjust to shifting priorities during the clinical research process. We pride ourselves on creative problem-solving, attributed to years of experience investigating new treatments and emerging infectious diseases.
Multisite Epidemiology Studies
Powered by data science, Westat’s epidemiologists look for the causes and risk factors of disease by studying patterns, frequencies, and preventive interventions across places and populations. Our research pushes the boundaries of public health knowledge, investigating important issues such as the household transmission rates of COVID-19 and the comparative effectiveness of FDA-approved influenza vaccines. We use innovative tools, including virtual data collection platforms and at-home participant specimen collection, to remotely conduct research across the country. This work aims to expand on existing scientific literature while increasing research inclusion, including among populations that are historically underrepresented in clinical studies.
Network Coordinating Centers
Coordinating centers are a key part of multicenter research initiatives; they’re centralized hubs that pool complex biomedical and administrative data from multiple research centers, then aggregate, manage, and analyze the data, and finally make the data accessible to researchers. Our management of coordinating centers helps collate public health data to provide insights on a range of issues. These data have revealed how environmental exposures affect human health over a lifetime, what research programs reduce HIV incidence rates in at-risk youth, and the effects of SARS-CoV-2 on community transmission and the blood supply. We have supported the investigation of underlying genetic components related to heart, lung, and blood disorders, coordinated the development of large-scale omics datasets to inform precision medicine initiatives, and so much more.
We build sophisticated data infrastructure to help our clients access, harmonize, and analyze real-world data to answer critical questions. Our systems assemble data from our integrated health care and hospital network partners to rapidly produce estimates of COVID-19 and influenza vaccine effectiveness and to characterize the clinical epidemiology of respiratory viruses, informing key policy decisions. Our research data platform and team have also supported national SARS-CoV-2 serosurveillance by collecting and analyzing blood donation data. Our experience with real-world data positions us to help our clients understand and respond to future pandemics.
Meet the Team
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)How does our support for clinical trials reduce new HIV infections and improve care for young people?
Children’s Hospital of PhiladelphiaHow do you meet data management and biostatistical expertise needs for a hospital?
National Cancer Institute (NCI)What can improve physician and patient access to NCI-sponsored clinical trials?
Deep Dive with Our Experts
PerspectiveCDISC Conformance and Compliance: So Many Resources, So Little Time!
Implementing the Clinical Data Interchange Standards Consortium (CDISC) standards required for data management, programming, documentation, and eCTD data submission can be challenging for many reasons…
PerspectiveSolving the Challenges to Clinical Trial Research in an Uncertain Economy
The global pandemic, in its early stages, brought a hailstorm of challenges to businesses, including the business of conducting clinical trials. While our Westat colleagues…
Journal ArticleAdams et al. respond to “Stop analyzing ‘despair’ deaths together”
American Journal of Epidemiology
R.S. Adams, T.L. Spark, C.A. Hoffmire, J.E. Forster, L.A. Brenner